This Friday, September 21, marks the 18th annual World Alzheimer's Day. Sponsored by Alzheimer's Disease International, this year's theme is "Dementia: Living Together," focused on reducing the stigma associated with dementia and creating a more inclusive society in which people with dementia and their families can live without fear of discrimination. This year also marks September as the first global World Alzheimer's Month.

As part of our efforts toward the diagnosis, treatment, and prevention of Alzheimer's disease and dementia, the Academy, in partnership with One Mind for Research, has launched the Alzheimer's Disease and Dementia Initiative. This initiative will develop actionable plans that marry the expertise, infrastructure, and resources of our partners with the Academy's core strengths of convening, publishing, training, mentoring, and fostering innovation through public/private partnerships. More information on this initiative will be available here at nyas.org in the coming months.

	Event The Paradox of Overnutrition in Aging and Cognition This conference explores the linkages between overnutrition and the aging process, especially its cognitive aspects.
	eBriefing Targeting the Vasculature in Alzheimer's Disease Current knowledge on the vascular connection to Alzheimer's pathogenesis and novel approaches to intervention for therapeutic development.
	eBriefing Epigenetics of Alzheimer's Disease The contribution of epigenetic modifications to the initiation and progression of Alzheimer's disease and possible applications of epigenetic therapeutics to slow or reverse its progress. Academy members only. To access, join now.
	eBriefing Targeting Synaptic Dysfunction in Alzheimer's Disease The mechanisms of synaptic plasticity in normal aging and in neurodegenerative disease and therapeutic strategies to preserve vital neural connections.
	Report Therapeutics for Cognitive Aging Free online meeting report provided by Annals of the New York Academy of Sciences. Includes developing therapeutic interventions for cognitive impairment, how to define cognitive aging, and whether cognitive aging should be considered a treatable, tractable disease.
	Webinar Is Alzheimer's Disease Type 3 Diabetes? What is the connection between dysregulated neuronal insulin signaling and Alzheimer's disease? Some researchers argue that the neurodegenerative disease should be considered a type of diabetes.
	Article Putting Brain Power Behind Brain Disease The New York Academy of Sciences partners with One Mind for Research to hasten the translation of Alzheimer's disease and dementia research.

External Resources

About the New York Academy of Sciences
The New York Academy of Sciences is an independent, not-for-profit organization that since 1817 has been committed to advancing science, technology, and society worldwide. With 25,000 members in 140 countries, the Academy is creating a global community of science for the benefit of humanity. The Academy's core mission is to advance scientific knowledge, positively impact the major global challenges of society with science-based solutions, and increase the number of scientifically informed individuals in society at large. Please visit us online at www.nyas.org.